A Partner in Diabetes Care: Henry Schein Medical Supports Health Care Professionals During Diabetes Awareness Month
HSIC 11.05.2024
About Gravity Analytica
Recent News
- 01.15.2025 - Henry Schein Completes Acquisition of Acentus
- 01.14.2025 - J.P. Morgan’s Healthcare Investor Conference
- 01.14.2025 - Henry Schein Opens Henry Schein Cares Foundation 2025 Relief Fund and Commits Up to $300,000 in Cash and Essential Health Care Supplies to Support the City of Los Angeles
Recent Filings
Company Offers Essential Tools For Holistic Diabetes Management
MELVILLE, N.Y., November 5, 2024– November marksAmerican Diabetes Month®, a time to raise awareness of diabetes and to support the 1.2 million Americans diagnosed with diabetes each year, and more than 38 million Americans affected by the disease1. To help health care professionals enhance care and improve health outcomes for patients with diabetes, Henry Schein is offering its comprehensive range of diabetes management solutions.
Henry Schein Medical’s diabetes care offerings include capital equipment, point of care diagnostics, laboratory, hypodermic and blood collection, and pharmaceutical solutions, such as:
- Capital Equipment:Baxter RetinaVue700 ImagerandMidmark steam sterilizers and chairs.
- Point of Care Diagnostics:Abbott AfinionTM 2 analyzer and Piccolo Xpress analyzers,HemoCue® Glucose 201 System and HemoCue® Hb 801 System,Henry Schein TRUE METRIX Pro Blood Glucose Meter Kit and OneStep+ Pro Hb Analyzer,PTS Diagnostics A1CNow and CardioChek® products,Siemens DCA Vantage analyzer, andVidan Diagnostics LucidplusTM B-Ketone Plus Blood Glucose Monitoring System.
- Laboratory:Beckman Coulter,Horiba, andSiemenschemistry and immunoassay analyzers.Tosoh Bioscienceimmunoassay analyzers, andSysmexhematology analyzers.
- Hypodermics and Blood Collection:Embecta productsandSol-Millennium lancets.
- Pharmaceuticals:Over-the-Counter Medications and Rx.
“At Henry Schein, we recognize the integral role health care professionals play in helping patients manage diabetes, while offering guidance, resources, and treatment,” said Stephanie Shen, Chief Product Officer for Henry Schein’s North America Distribution Group. “To help practitioners effectively manage patients’ diabetes, Henry Schein provides access to a wide range of tools in a single place, from point-of-care diagnostics to remote patient monitoring. Together with our supplier partners, we are a trusted partner in helping practitioners enhance diabetes care.”
Also available through Henry Schein Medical isRimidi. Itsremote patient monitoring solutionfor diabetes connects patient-generated data from connected devices like blood glucose monitors, continuous glucose monitors, and insulin pens with clinical data in electronic health record (EHR) systems. This helps give clinicians a more complete view of a patient’s health and drives patient-specific clinical insights and actions within the framework of the latest evidence and guidelines. The platform lives within the EHR—integrating seamlessly into the provider workflow.Click herefor a video from Dr. Lucienne Ide, Founder and CEO of Rimidi, who highlights three trends to watch in diabetes care.
In addition to its products and solutions, this year the Henry Schein Cares Foundation, Inc. (HSCF) launchedPrevention is PowerTM, a multi-year public health awareness campaign aimed at supporting patient adoption of a preventive, integrated health care model to improve overall health outcomes. Part of the program is to provide health care practitioners with tools to advance understanding of the connection between oral health and overall health, with one of the focus areas being diabetes and oral health.Click herefor more details about Prevention is Power.
For more information about Henry Schein Medical and its diabetes care products,click here.
1American Diabetes Association. Diabetes By-the-Numbers.https://diabetes.org/.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 26,000Team Schein Membersworldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-baseddentalandmedicalpractitioners work more efficiently so they can provide quality care more effectively. These solutions also supportdental laboratories,government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.3 billion in 2023, and have grown at a compound annual rate of approximately 11.5 percent since Henry Schein became a public company in 1995.
For more information, visit Henry Schein atwww.henryschein.com,Facebook.com/HenrySchein,Instagram.com/HenrySchein,LinkedIn.com/Company/HenrySchein,and@HenrySchein on X.
CONTACT:
Lauren DelGuidiceSenior Corporate Media Relations Specialistlauren.delguidice@henryschein.com631.479.7309
###